Sarcopenia in Chronic Lung Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorTaichung Veterans General Hospital
About this trial
Inclusion criteria A)Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.
B) Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.
Those who meet the conditions for frailty diagnosis after assessment by the Frailty Scale
Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources
Age>=20
Disqualifiers
Patients who refuse to sign the consent form
Patients who are bed ridden or unable to walk due to physical disabilities
Patients with terminal cancer or human acquired immunodeficiency syndrome
Patients with edema (pitting edema +2)
Trial population
* Baseline demographic characteristic, health behavior and exercise habits are collected by questionnaires.The main disease diagnosis, medication, clinical assessment questionnaire or biochemical examination and radiological examination results in outpatient visit are collected. * According to the 2019 Asian Sarcopenia Consensus, participants are examined by SARC-Calf questionnaire, grip strength test, frailty index and a physical performance test,including sit-stand test, short physical performance battery (SPPB), gait speed test and six-minute walk test. Afterward, bioelectrical impedance analysis (BIA) are applied to all participants by to analyze body composition. Participants are classified into Sarcopenia group and severe Sarcopenia group.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
sarcopenia rate
The proportion of sarcopenia diagnosis in patients with chronic lung diseases
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov